Stock MBRX MOLECULIN BIOTECH, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart Moleculin Biotech, Inc.

Equities

MBRX

US60855D3098

Market Closed - Nasdaq
Other stock markets
 02:00:00 06/07/2024 am IST 		5-day change 1st Jan Change
3.49 USD -3.86% Intraday chart for Moleculin Biotech, Inc. -0.85% -72.90%
14/06 Moleculin Biotech, Inc. Announces Additional Positive Preliminary Interim Data from AML Clinical Trial CI
15/05 Moleculin Announces Commencement of NIH-Funded Phase 2 Clinical Trial of STAT3 Inhibitor for the Treatment of Glioblastoma (Nu 21C06) CI

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
MOLECULIN BIOTECH, INC.
Bio Therapeutic Drugs
-3.86%-0.85%-72.90%-59.31%-96.77% 80.67L
Bearish
Bearish
Bearish
  1. Stock Market
  2. Equities
  3. MBRX Stock
  4. Charts Moleculin Biotech, Inc.
  5. Relative Strength Chart